ABN Newswire: Regeneus CEO John Martin Talks About the Licensing of Progenza in Japan - See more at: http://regeneus.com.au/about/news/a...licensing-progenza-japan#sthash.OXjXjV6P.dpuf
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
